Veytics Intelligence
2026-11-06 · Marketwatch

Hims & Hers struck a GLP-1 deal with Lilly. Its stock is rallying.

Bản dịch chưa sẵn sàng. Đang hiển thị bài viết gốc.

As part of the agreement, Hims said it won’t compound GLP-1 medications like Zepbound in the future.

Doc ban tin day du cua Veytics

Chung toi hien cong khai y chinh. Tao tai khoan mien phi de doc toan bo bai viet, luu, thao luan va ket noi voi boi canh thi truong va OSINT.